- Home
- CRNX vs FICO Comparison
CRNX vs FICO Comparison
Compare CRNX & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | FICO |
|---|---|---|
| Founded | 2008 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 34.7B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CRNX | FICO |
|---|---|---|
| Price | $37.23 | $1,158.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $74.78 | ★ $1,961.08 |
| AVG Volume (30 Days) | ★ 846.2K | 302.6K |
| Earning Date | 06-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.78 |
| EPS | N/A | ★ 6.61 |
| Revenue | $1,039,000.00 | ★ $1,032,475,000.00 |
| Revenue This Year | $730.30 | $27.68 |
| Revenue Next Year | $179.48 | $17.15 |
| P/E Ratio | ★ N/A | $171.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.10 | $1,068.67 |
| 52 Week High | $57.99 | $2,217.60 |
Technical Indicators
Market Signals| Indicator | CRNX | FICO |
|---|---|---|
| Relative Strength Index (RSI) | 29.09 | 33.64 |
| Support Level | $33.23 | N/A |
| Resistance Level | $45.32 | $1,562.48 |
| Average True Range (ATR) | 1.85 | 67.68 |
| MACD | -0.10 | -24.00 |
| Stochastic Oscillator | 19.45 | 21.10 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.